SEARCH

SEARCH BY CITATION

References

  • Breysse, N, Carlsson, T, Winkler, C, Björklund, A & Kirik, D. (2007) The functional impact of the intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease. J. Neurosci., 27, 58495856.
  • Brown, P & Gerfen, CR. (2006) Plasticity within striatal direct pathway neurons after neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK 1/2 map kinase pathway. J. Comp. Neurol., 498, 415430.
  • Brundin, P, Karlsson, J, Emgard, M, Schierle, GS, Hansson, O, Petersen, A & Castilho, RF. (2000) Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant., 9, 179195.
  • Caligiuri, MP & Lohr, JB. (1993) Worsening of postural tremor in patients with levodopa-induced dyskinesia: a quantitative analysis. Clin. Neuropharmacol., 16, 244250.
  • Collier, TJ, Lipton, J, Daley, BF, Palfi, S, Chu, Y, Sortwell, C, Bakay, RA, Sladek, JR Jr & Kordower, JH. (2007) Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol. Dis., 26, 5665.
  • Day, M, Wang, Z, Ding, J, An, X, Ingham, CA, Shering, AF, Wokosin, D, Ilijic, E, Sun, Z, Sampson, AR, Mugnaini, E, Deutch, AY, Sesack, SR, Arbuthnott, GW & Surmeier, DJ. (2006) Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci., 9, 251259.
  • Deutch, AY. (2006) Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson’s disease. J. Neural Transm. Suppl., 70, 6770.
  • Dunah, AW, Sirianni, AC, Fienberg, AA, Bastia, E, Schwarzschild, MA & Standaert, DG. (2004) Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. Mol. Pharmacol., 65, 121129.
  • Fahn, S. (2000) The spectrum of levodopa-induced dyskinesias. Ann. Neurol., 47, S2S9.
  • Finger, S & Dunnett, SB. (1989) Nimodipine enhances growth and vascularization of neural grafts. Exp. Neurol., 104, 19.
  • Freed, CR, Greene, PE, Breeze, RE, Tsai, WY, DuMouchel, W, Kao, R, Dillon, S, Winfield, H, Culver, S, Trojanowski, JQ, Eidelberg, D & Fahn, S. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344: 710719.
  • Freund, TF, Bolam, JP, Bjorkland, A, Stenevi, U, Dunnett, SB, Powell, JF & Smith, AD. (1985) Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J. Neurosci., 5, 603616.
  • Guerra, MJ, Liste, I & Labandeira- Garcia, JL. (1997) Effects of lesions of the nigrostriatal pathway and of nigral grafts on striatal serotonergic innervation in adult rats. Neuroreport, 8, 34853488.
  • Kirik, D, Winkler, C & Bjorklund, A. (2001) Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J. Neurosci., 21, 28892896.
  • Kordower, JH, Freeman, TB, Snow, BJ, Vingerhoets, FJ, Mufson, EJ, Sanberg, PR, Hauser, RA, Smith, DA, Nauert, GM, Perl, DP & Olanow, W. (1995) Neuropathological evidence of graft survival and striatal reinnervation after transplantation of fetal mesencephalic tissue in a patient with Parkinson’s disease. N. Engl. J. Med., 332, 11181124.
  • Langston, JW & Ballard, P. (1984) Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and pathogenesis of Parkinson’s disease. Can. J. Neurol. Sci., 11, 160165.
  • Leranth, C, Sladek, JR Jr, Roth, RH & Redmond, DE. Jr (1998) Efferent synaptic connections of dopaminergic neurons grafted into the caudate nucleus of experimentally induced parkinsonian monkeys are different from those of control animals. Exp. Brain Res., 123, 323333.
  • Linazasoro, G. (2009) A global view of Parkinson’s disease pathogenesis: implications for natural history and neuroprotection. Parkinsonism Relat. Disord., 15, 401405.
  • Lundblad, M, Andersson, M, Winkler, C, Kirik, D, Wierup, N & Cenci, MA. (2002) Pharmacological validation of behavioral measures of akinesia and dyskinesia in a rat model of Parkinson’s disease. Eur. J. Neurosci., 15, 120132.
  • Maeda, T, Nagata, K, Yoshida, Y & Kannari, K. (2005) Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA. Brain Res., 1046, 230233.
  • Mahalik, TJ, Finger, TE, Stromberg, I & Olson, L. (1985) Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections. J. Comp. Neurol., 240, 6070.
  • Maries, E, Kordower, JH, Chu, Y, Collier, TJ, Sortwell, CE, Olaru, E, Shannon, K & Steece-Collier, K. (2006) Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol. Dis., 21, 165180.
  • McNeill, TH, Brown, SA, Rafols, JA & Shoulson, I. (1988) Atrophy of medium spiny I striatal dendrites in advanced Parkinson’s disease. Brain Res., 455, 148152.
  • Meredith, GE, De Souza, IE, Hyde, TM, Tipper, G, Wong, ML & Egan, MF. (2000) Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias. J. Neurosci., 20, 77987806.
  • Meurers, BH, Dziewczapolski, G, Shi, T, Bittner, A, Kamme, F & Shults, CW. (2009) Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons. J. Neurosci., 29, 68286839.
  • Mones, RJ, Elizan, TS & Seigel, GJ. (1971) Analysis of (- DOPA dyskinesia in 51 patients with parkinsonism. J. Neurol. Neurosurg. Psychiatry, 34, 668673.
  • Neely, MD, Schmidt, DE & Deutch, AY. (2007) Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons. Neuroscience, 149, 457464.
  • Olanow, CW, Goetz, CG, Kordower, JH, Stoessl, AJ, Sossi, V, Brin, MF, Shannon, KM, Nauert, GM, Perl, DP, Godbold, J & Freeman, TB. (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Ann. Neurol., 54, 403414.
  • Picconi, B, Ghiglieri, V, Bagetta, V, Barone, I, Sgobio, C & Calabresi, P. (2008) Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD. Parkinsonism Relat. Disord., 14(Suppl. 2), S145S149.
  • Robinson, TE & Kolb, B. (2004) Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology, 47, 3346.
  • Schallert, T. (2006) Behavioral tests for preclinical intervention assessment. NeuroRx, 3, 497504.
  • Schallert, T, Fleming, SM, Leasure, JL, Tillerson, JL & Bland, ST. (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology, 39, 777787.
  • Schuster, S, Doudnikoff, E, Rylander, D, Berthet, A, Aubert, I, Ittrich, C, Block, B, Cenci, MA, Surmeier, DJ, Hengerer, B & Bezard, E. (2009) Antagonizing L-type Ca2+ channel reduceds development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biol. Psychiatry, 65, 518526.
  • Soderstrom, KE, Meredith, G, Freeman, TB, McGuire, SO, Collier, TJ, Sortwell, CE, Wu, Q & Steece-Collier, K. (2008) The synaptic impact of the host immune response in a parkinsonian allograft rat model: influence on graft-derived aberrant behaviors. Neurobiol. Dis., 32, 229242.
  • Steece-Collier, K, Yurek, DM, Collier, TJ, Junn, FS & Sladek, JR. Jr (1995) The detrimental effect of levodopa on behavioral efficacy of fetal dopamine grafts in rats is irreversible following prolonged withdrawal of chronic dosing. Brain Res., 676, 404408.
  • Steece-Collier, K, Collier, TJ, Danielson, PD, Kurlan, R, Yurek, DM & Sladek, JR. Jr (2003) Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesias in parkinsonian rats. Mov. Disord., 18, 14421454.
  • Stephens, B, Mueller, AJ, Shering, AF, Hood, SH, Taggart, P, Arbuthnott, GW, Bell, JE, Kilford, L, Kingsbury, AE, Daniel, SE & Ingham, CA. (2005) Evidence of a breakdown of corticostriatal connections in Parkinson’s disease. Neuroscience, 132, 741754.
  • Truong, D & Wolters, E. (2009) Recognition and management of Parkinson’s disease during the premotor (prodromal) phase. Expert Rev Neurother, 9, 847857.
  • Winkler, C, Kirik, D & Björklund, A. (2005) Cell transplantation in Parkinson’s disease: how can we make it work? Trends Neurosci., 28, 8692.
  • Zaja-Milatovic, S, Milatovic, D, Schantz, AM, Zhang, J, Montine, KS, Samii, A, Deutch, AY & Montine, TJ. (2005) Dendritic degeneration in neostriatal medium spiny neurons in Parkinson’s disease. Neurology, 64, 545547.